Corteva, Inc. (CTVA - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for Corteva, Inc. is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Corteva, Inc. imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for Corteva, Inc.For the fiscal year ending December 2026, this agriculture is expected to earn $3.76 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Corteva, Inc.. Over the past three months, the Zacks Consensus Estimate for the company has increased 3.7%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Corteva, Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Key Takeaways Corteva's Q2 EPS estimate is $2.22, up 0.91%, while revenues of $6.61B imply a 2.4% decline.Premium seeds, disciplined pricing and favorable product mix are expected to support Seed revenues.Productivity and lower input costs may cushion pricing, inflation and geopolitical pressures. Corteva, Inc. (CTVA - Free Report) is likely to witness growth in its top and bottom lines when it reports second-quarter fiscal 2026 results on July 30, after the opening bell. The Zacks Consensus Estimate for quarterly revenues is pegged at $6.61 billion, indicating a 2.4% dip from the prior-year quarter’s figure.
The Zacks Consensus Estimate for earnings is pegged at $2.22 per share, which indicates growth of 0.91% from the year-ago quarter’s registered numbers. The consensus mark has increased by 2 cents over the past 30 days.
CTVA delivered an earnings surprise of 27.1% in the last reported quarter. In the trailing four quarters, the company’s earnings beat the Zacks Consensus Estimate by 25.3%.
Key Factors to Influence CTVA’s Q2 ResultsCorteva's second-quarter 2026 performance is likely to have benefited from healthy demand across its Seed business, supported by favorable planting conditions in North America and continued adoption of premium seed technologies. Management indicated that farmers continued to prioritize high-yielding hybrids and trait technologies despite a cautious spending environment, with strong demand for Pioneer products, Brevant retail offerings and Enlist soybean technology. The company also noted that pricing discipline and favorable product mix across regions are expected to remain supportive of Seed revenues.
Crop Protection revenues are also likely to have benefited from continued volume growth, driven by robust demand for differentiated products and biological solutions. Corteva has been witnessing strong momentum in new products and spinosyn insecticides across regions, while management expects Latin America to remain a key growth driver. Increasing adoption of biological products, including Utrisha and BlueN, along with favorable pest pressure, is likely to have supported volumes during the quarter, partly offsetting ongoing pricing pressure in the Crop Protection business.
Margin performance is likely to have benefited from Corteva's continued focus on productivity initiatives and lower input costs. Management expects productivity gains across both the Seed and Crop Protection businesses, while lower seed commodity costs and improving royalty economics should continue to aid profitability. The company's progress toward becoming royalty-positive, coupled with disciplined cost management, is expected to have provided a meaningful cushion against higher selling expenses and ongoing investments in the business.
However, the quarter is likely to have been affected by persistent pricing pressure in Crop Protection, particularly in Latin America, amid a competitive market environment. In addition, higher oil prices, geopolitical uncertainties and inflationary pressures remain challenges, although management stated that tariff trends have been somewhat more favorable than previously anticipated and mitigation efforts are underway. While these headwinds are expected to have weighed on profitability, strong operational execution and resilient demand for Corteva's premium technologies are likely to have partly offset their impact.
What the Zacks Model Unveils for CTVAOur proven model conclusively predicts an earnings beat for CTVA this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.
Corteva currently has an Earnings ESP of +4.81% and a Zacks Rank of 3. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Valuation Picture of CTVA StockThe company has a forward 12-month price-to-earnings ratio of 22.73X, which is above the Agriculture - Operations industry’s average of 16.13X.
Image Source: Zacks Investment Research
The recent market movements show that CTVA shares have risen 11.8% in the past three months compared with the industry's 12.9% growth.
Image Source: Zacks Investment Research
Other Stocks With the Favorable CombinationHere are some other companies worth considering, as our model shows that these also have the right combination of elements to beat on earnings this reporting cycle.
Kimberly-Clark Corporation (KMB - Free Report) currently has an Earnings ESP of +1.43% and a Zacks Rank of 3. The Zacks Consensus Estimate for Kimberly-Clark’s upcoming quarterly revenues is pegged at $4.23 billion. The figure implies a 1.7% increase from the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Kimberly-Clark’s quarterly earnings per share (EPS) is pegged at $2, indicating a 4.2% gain from the year-ago period figure. KMB delivered a trailing four-quarter earnings surprise of 19.1%, on average.
Archer-Daniels-Midland Company (ADM - Free Report) currently has an Earnings ESP of +11.52% and a Zacks Rank of 2. The consensus estimate for ADM’s quarterly revenues is pinned at $22.38 billion, which calls for 5.7% growth from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Archer-Daniels’ quarterly EPS is pegged at $1.27, which implies a 36.6% rise year over year. ADM delivered a trailing four-quarter earnings surprise of 5.4%, on average.
Monster Beverage Corporation (MNST - Free Report) currently has an Earnings ESP of +2.61% and a Zacks Rank of 3. The consensus estimate for revenues is pinned at $2.42 billion, which suggests 14.5% growth from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Monster Beverage’s quarterly EPS is pegged at 59 cents, which implies a 13.5% increase year over year. MNST delivered a trailing four-quarter earnings surprise of 9.6%, on average.
, /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors has authorized a common stock dividend of $0.18 cents per share, payable September 15, 2026, to the Company's shareholders of record on September 1, 2026.
EIDP, Inc. Announces Preferred Stock Dividend
The Board of Directors of EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) (EIDP) declared regular preferred stock dividends of $1.12-1/2 per share on the $4.50 series preferred stock and $0.87-1/2 per share on the $3.50 series preferred stock – both payable October 23, 2026, to EIDP stockholders of record on October 2, 2026. EIDP, Inc. is a wholly owned subsidiary of Corteva, Inc.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
ABN Amro Investment Solutions decreased its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 59.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 63,821 shares of the company’s stock after selling 93,474 shares during the quarter. ABN Amro Investment Solutions’ holdings in Corteva were worth $5,342,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. Drummond Knight Asset Management Pty Ltd acquired a new stake in shares of Corteva during the 4th quarter worth about $25,713,000. Arbejdsmarkedets Tillaegspension acquired a new position in Corteva in the 4th quarter valued at about $23,679,000. Mirae Asset Global Investments Co. Ltd. grew its stake in Corteva by 23.5% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after buying an additional 20,957 shares during the last quarter. Leonteq Securities AG bought a new position in Corteva in the 4th quarter valued at about $2,350,000. Finally, Brandes Investment Partners LP lifted its position in Corteva by 1.1% during the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.
Wall Street Analyst Weigh In CTVA has been the subject of a number of research analyst reports. Wells Fargo & Company boosted their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Barclays lifted their price target on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Jefferies Financial Group boosted their price target on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Morgan Stanley upped their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Finally, BNP Paribas Exane boosted their target price on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.90.
Discover more
Military satellite technology
Defense industry events
Business Finance
Check Out Our Latest Research Report on CTVA
Corteva Price Performance Shares of NYSE:CTVA opened at $88.56 on Thursday. The firm has a 50 day moving average of $81.13 and a 200-day moving average of $78.69. The stock has a market capitalization of $59.23 billion, a PE ratio of 52.09, a PEG ratio of 2.64 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $88.57.
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the business posted $1.13 EPS. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts predict that Corteva, Inc. will post 3.75 EPS for the current fiscal year.
Corteva Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s payout ratio is currently 42.35%.
Corteva Profile (Free Report)
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles Five stocks we like better than Corteva Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINE6,000 Shares in American Tower Corporation $AMT Bought by AR Asset Management Inc.
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Corteva, Inc. (CTVA - Free Report) . This company, which is in the Zacks Agriculture - Operations industry, shows potential for another earnings beat.
This agriculture has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 15.94%.
For the most recent quarter, Corteva, Inc. was expected to post earnings of $1.18 per share, but it reported $1.5 per share instead, representing a surprise of 27.12%. For the previous quarter, the consensus estimate was $0.21 per share, while it actually produced $0.22 per share, a surprise of 4.76%.
Price and EPS Surprise
With this earnings history in mind, recent estimates have been moving higher for Corteva, Inc.. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Corteva, Inc. currently has an Earnings ESP of +4.81%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 30, 2026.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Amova Asset Management Americas Inc. reduced its holdings in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 6.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 274,132 shares of the company’s stock after selling 18,258 shares during the quarter. Amova Asset Management Americas Inc.’s holdings in Corteva were worth $22,948,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its stake in Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after purchasing an additional 317,538 shares during the last quarter. State Street Corp lifted its position in shares of Corteva by 3.7% during the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after buying an additional 1,290,071 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Corteva by 4.3% during the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after buying an additional 805,873 shares during the last quarter. Harris Associates L P boosted its holdings in shares of Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares in the last quarter. Finally, Northern Trust Corp grew its position in shares of Corteva by 5.0% in the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after buying an additional 562,550 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.
Corteva Price Performance Shares of NYSE:CTVA opened at $86.85 on Tuesday. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a market cap of $58.09 billion, a P/E ratio of 51.09, a PEG ratio of 2.67 and a beta of 0.56. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $88.21. The company has a 50-day moving average price of $80.94 and a 200 day moving average price of $78.40.
Corteva (NYSE:CTVA – Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.
Corteva Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s payout ratio is 42.35%.
Wall Street Analysts Forecast Growth Several equities analysts have issued reports on the stock. Mizuho upped their price objective on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Berenberg Bank lifted their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. Morgan Stanley boosted their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. The Goldman Sachs Group raised their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Finally, Bank of America upped their price target on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $89.62.
View Our Latest Stock Analysis on Corteva
About Corteva (Free Report)
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Recommended Stories Five stocks we like better than Corteva The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINERoyal Bank Of Canada Issues Positive Forecast for Fifth Third Bancorp (NASDAQ:FITB) Stock Price
NEXT HEADLINE »Amova Asset Management Americas Inc. Has $39.56 Million Holdings in Archer Aviation Inc. $ACHR
The partnership will help farmers in Europe improve nutrient use efficiency July 03, 2026 10:00 ET | Source: Arevo
UMEÅ, July 03, 2026 (GLOBE NEWSWIRE) -- Corteva, a global pure-play agriculture company, and Arevo, a Swedish science-led crop nutrition company, have announced a partnership on Arginex Soy, Arevo’s seed applied crop nutrition system.
Corteva and Arevo Partner on Soy Crop Nutrition
Arginex Soy is an innovative arginine1-based seed treatment designed to strengthen root systems, increase nodulation and improve soybean performance, offering growers a new way to boost yields and crop resilience while advancing more sustainable production practices.
In soybeans, arginine helps stimulate the growth of root hairs, which are important for the formation of nodules where beneficial nitrogen-fixing bacteria take hold. This helps strengthen the plant’s natural ability to fix nitrogen and supports healthier root development and more efficient nutrient use from the earliest stages of growth.
Corteva is integrating the product, which is already available to farmers in Europe, into its soybean seed treatment portfolio to help get crops off to the best start.
The agreement follows a multi-stage technical evaluation assessing agronomic performance, formulation stability, and operational compatibility with Corteva’s existing soybean seed treatment portfolio.
The evaluation confirmed that Arginex Soy can deliver measurable crop performance benefits while fitting seamlessly into existing seed treatment processes, reducing barriers to adoption and enabling growers to access the technology through established commercial channels.
Leonardo Costa, EMEA Seed Applied Technologies Leader, Corteva Agriscience, said: “Rigorous evaluation has confirmed that Arginex Soy delivers the consistency and formulation stability required for Corteva’s seed applied technologies. This enables seamless integration into existing systems and provides farmers with a practical solution to support early crop establishment and improve nutrient use efficiency from the start.”
Niklas Åström, Chief Executive Officer, Arevo, said: “Being selected following this level of technical evaluation is an important milestone for Arevo. It confirms that Arginex can be integrated into established seed platforms.”
1 Arginine is an organic nitrogen source that plants absorb preferentially. Combined with phosphate, it forms a stable compound designed to remain available in the root zone over time.
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
Follow Corteva on Facebook, Instagram, LinkedIn and YouTube.
# # #
July 3, 2026
™ ® Trademarks of Corteva Agriscience and its affiliated companies.
About Arevo
Arevo is a Swedish science-led crop nutrition company. Its arginine-based technology, Arginex, is designed to enhance a plant’s natural ability to absorb nutrients and water, support beneficial soil microbes, and produce stronger, more resilient crops. Built commercially for agriculture, forestry and horticulture, Arevo’s mission is to reduce dependence on synthetic fertilisers and support more sustainable cultivation practices with zero nitrogen waste. Learn more at www.arevo.se.
Karen Grimes to be Chair; separation on track for 4Q 2026
, /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today the board of directors for Vylor Inc., the future publicly traded, advanced seed and genetics company that will result from the current company's planned separation.
Karen Grimes will lead the board as Independent Chair. Grimes joined Corteva's board of directors in March 2021 and was previously senior managing director, partner, and equity portfolio manager at Wellington Management Company LLP, an investment management firm. She began her career as a field engineer in the Atlanta office at IBM after serving for three years in the U.S. Army. Grimes also serves as a director of Toll Brothers, Inc., a company that develops and builds luxury residential communities across the U.S., since March 2019.
"Vylor will be a company dedicated to leveraging its expertise in advanced seed and genetics to help farmers feed and fuel the world. I look forward to working with my fellow directors as well as the Vylor senior management team to accelerate the company's growth and impact – and continue to deliver results for shareholders," said Grimes.
The appointments to the board of seven directors will be effective at separation, which remains on track for the fourth quarter of 2026. A search is ongoing for at least one additional board member.
The Future Vylor Board of Directors
Karen Grimes, retired partner, senior managing director and equity portfolio manager, Wellington Management Company, non-executive chair of the board Victor Aguilar, chief research, development and innovation officer, The Procter & Gamble Company Rajesh "Raj" Kalathur, Rajesh "Raj" Kalathur, former president, John Deere Financial, former chief information officer and chief financial officer, Deere & Company Marcos Lutz, chairman, former chief executive officer, Ultrapar Participacões S.A. Chuck Magro, future chief executive officer, Vylor Johannes "Jannie" J. Oosthuizen, executive vice president and president, oncology and MSD International, Merck & Co., Inc. Kerry Preete, retired executive vice president and chief strategy officer, Monsanto Company Vylor's innovation engine will be anchored in the agriculture industry's most elite germplasm and transformative biotech. The company will leverage its next generation scientific expertise in disciplines like gene editing and molecular breeding to further strengthen its core business while exploring opportunities to expand to new row crops – and potentially beyond. Vylor will scale these innovations using its leading routes-to-market and by significantly expanding its licensing business.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
Cautionary Statement on Forward-Looking Statements
This press release contains certain forward-looking statements. Words such as "will," "plan," "may," "expect," "see," and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for Corteva and Vylor. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's control.
Important factors that may affect Corteva's business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended separation could have an adverse effect on the ability of Corteva to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the separation could divert the attention and time of the company's management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties described in Corteva's risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. Corteva disclaims and does not undertake any obligation to update, revise, or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.
Greg Page to be Chair; separation on track for 4Q 2026
, /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today its intended board of directors as a standalone publicly-traded, differentiated crop protection company upon its planned separation in the fourth quarter of 2026.
Greg Page will lead the nine-person board as Independent Chair as previously announced. With the exception of Karen Grimes, Marcos Lutz, Chuck Magro and Kerry Preete, Corteva's existing board of directors will continue with Corteva. Luke Kissam will be appointed to the board of directors effective at separation.
"Corteva will be a company with operational efficiency at its core and by building on its legacy of differentiated innovation, will have an industry leading pipeline to bring value to farmers for years to come," said Page. "I look forward to working alongside my future fellow directors as well as the senior management team to leverage the considerable advantage Corteva will enjoy to deliver results for customers, farmers and shareholders alike."
New Corteva Board of Directors
Greg Page, retired chairman and chief executive officer, Cargill, Incorporated, non-executive chair of the board Klaus Engel, Ph.D., retired chief executive officer, Evonik Industries AG David Everitt, retired president, Agricultural and Turf Division, Deere & Co. Janet Giesselman, retired president and general manager, Dow Oil & Gas Jean-Marc Gilson, president and chief executive officer, Westlake Corporation Luke Kissam, future chief executive officer, Corteva Nayaki Nayyar, chief executive officer, Siteimprove A/S Christopher Policinski, retired president and chief executive officer, Land O'Lakes, Inc. Patrick Ward, retired chief financial officer, Cummins Inc. New Corteva will be innovation-driven in both its product portfolio and its operating model, leveraging its technological leadership to deliver for farmers while also running an asset-light, efficient business. The company intends to make targeted investments to support growth and leverage its first-mover advantage in nature-inspired technologies to pursue opportunities promising attractive returns in markets that reward differentiation.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
Cautionary Statement on Forward-Looking Statements
This press release contains certain forward-looking statements. Words such as "will," "plan," "may," "expect," "see," "intend," and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for Corteva and Vylor Inc. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's control.
Important factors that may affect Corteva's business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended separation could have an adverse effect on the ability of Corteva to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the separation could divert the attention and time of the company's management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties described in Corteva's risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. Corteva disclaims and does not undertake any obligation to update, revise, or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.
Comerica Bank decreased its position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 248,243 shares of the company’s stock after selling 12,068 shares during the period. Comerica Bank’s holdings in Corteva were worth $16,640,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in CTVA. Brighton Jones LLC increased its position in Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after buying an additional 11,760 shares during the period. Woodline Partners LP increased its position in Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after buying an additional 16,644 shares during the period. EverSource Wealth Advisors LLC increased its position in Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after buying an additional 980 shares during the period. Cresset Asset Management LLC increased its position in Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after buying an additional 181 shares during the period. Finally, Jump Financial LLC acquired a new position in Corteva during the second quarter worth approximately $1,464,000. Institutional investors and hedge funds own 81.54% of the company’s stock.
Corteva Stock Down 0.6% CTVA opened at $78.95 on Wednesday. The business’s fifty day moving average is $80.26 and its two-hundred day moving average is $71.94. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The company has a market cap of $53.00 billion, a price-to-earnings ratio of 49.97, a PEG ratio of 2.72 and a beta of 0.68. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63.
Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts anticipate that Corteva, Inc. will post 3.62 EPS for the current fiscal year.
Corteva Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is presently 45.57%.
Insider Buying and Selling In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.15% of the company’s stock.
Analysts Set New Price Targets A number of research firms have recently issued reports on CTVA. Jefferies Financial Group boosted their target price on Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Mizuho boosted their target price on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Berenberg Bank boosted their target price on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, UBS Group boosted their target price on Corteva from $80.00 to $88.00 and gave the company a “neutral” rating in a report on Thursday, April 9th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $85.19.
Read Our Latest Stock Report on Corteva
Corteva Profile (Free Report)
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles Five stocks we like better than Corteva
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEEagle Wealth Advisors LLC Acquires New Position in Walmart Inc. $WMT
NEXT HEADLINE »United Rentals, Inc. $URI Shares Sold by Comerica Bank
New directors replace retiring directors, bring food, agriculture and chemical expertise
, /PRNewswire/ -- Corteva, Inc. today announced that its shareholders have approved the addition of Christopher Policinski and Jean-Marc Gilson to its board of directors. As previously announced, Lamberto Andreotti and Michael Johanns retired with this year's annual meeting of shareholders.
"We are pleased to welcome Chris and Jean-Marc to the Corteva Board – their expertise in the agriculture and chemicals sectors, respectively, will both strengthen the Board and serve Corteva well, particularly as the company moves forward with its plans to separate into two industry-leading companies," said Corteva Board Chair Gregory Page.
Page added, "On behalf of the entire Board, I want to thank Lamberto and Michael for their outstanding service to Corteva. Their efforts have helped guide Corteva to its current position of strength and laid a strong foundation for continued growth and success. We wish them both the best in their new chapters."
As previously communicated, board of directors appointments for "SpinCo" and "New Corteva" will be made in the second half of 2026.
About Chris Policinski
Policinski is the former president and chief executive officer of Land O'Lakes, Inc., a privately held agricultural cooperative specializing in dairy products, animal nutrition, and crop production, from 2005 to 2018. He joined Land O'Lakes in 1997 and held a variety of key leadership positions, including vice president, strategy and business development; executive vice president, dairy foods; and chief operating officer, dairy foods. Policinski has served on the board of directors of Hormel Foods Corp. since 2012, and from 2016 to 2023 served as the lead independent director. He previously served on the board of directors of Xcel Energy Inc. from 2009 to 2025, where he was also the lead independent director from 2016 to 2023.
About Jean-Marc Gilson
Gilson is the president and chief executive officer and member of the board of directors of Westlake Corporation, a global manufacturer and supplier of vinyl, polymers and building products, a position he has held since July 2024. Prior to this appointment, he was the president and chief executive officer and member of the board of directors of Mitsubishi Chemical Group Corporation from April 2021 to June 2024. Previously, Gilson served as chief executive officer of Roquette Frères, a global leader in plant-based ingredients and pharmaceutical excipients, from 2014 to 2021; chief operating officer of NuSil Technology LLC, a leading manufacturer of medical and space-grade silicone technology, from 2012 to 2014; and as chief executive officer of Avantor Performance Materials, Inc. from 2011 to 2012. Earlier in his career, he held a variety of key leadership positions at the Dow Corning Corporation.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
Cautionary Statement on Forward-Looking Statements
This press release contains certain forward-looking statements. Words such as "will," "plan," "may," "expect," "see," and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for New Corteva and SpinCo. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's control.
Important factors that may affect Corteva's business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended separation could have an adverse effect on the ability of Corteva to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the separation could divert the attention and time of the company's management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties described in Corteva's risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. Corteva disclaims and does not undertake any obligation to update, revise, or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Corteva, Inc. (CTVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2026.
New brand builds upon century-long legacy, reflects ambition to advance science to feed and fuel the world INDIANAPOLIS, May 4, 2026 /PRNewswire/ -- Corteva (NYSE: CTVA) announced today that the company that will comprise its current advanced seed and genetics business, previously referred to as "SpinCo," will be branded Vylor, Inc. Corteva's planned separation remains on track for the fourth quarter of 2026. With more than 4,000 germplasm patents and more than 2,000 biotechnology patents, Vylor's innovation engine will be anchored in the industry's most elite germplasm and transformative biotechnology, including a world-class pipeline that includes gamechangers like proprietary hybrid wheat, leadership in gene editing, multi-disease resistance corn and next-generation biofuels.
First quarter sales reflect strength of Seed and Crop Protection technology portfolios and progress on growth platforms Continued productivity and cost initiatives across both businesses further improve financial position Full-year 2026 guidance3 reaffirmed, including progress on 2027 value framework INDIANAPOLIS, Ind., May 5, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the first quarter ended March 31, 2026.
Corteva, Inc. (CTVA) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.13 per share a year ago.
For the quarter ended March 2026, Corteva, Inc. (CTVA - Free Report) reported revenue of $4.91 billion, up 11.1% over the same period last year. EPS came in at $1.50, compared to $1.13 in the year-ago quarter.
The reported revenue represents a surprise of +5.58% over the Zacks Consensus Estimate of $4.65 billion. With the consensus EPS estimate being $1.18, the EPS surprise was +27.36%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Corteva, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Sales- Seed: $3.02 billion compared to the $2.88 billion average estimate based on three analysts. The reported number represents a change of +11.7% year over year.Net Sales- Crop Protection: $1.88 billion versus the three-analyst average estimate of $1.79 billion. The reported number represents a year-over-year change of +10.1%.Net Sales- Crop Protection- Other: $74 million versus $121.64 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -41.3% change.Net Sales- Seed- Other: $99 million versus the two-analyst average estimate of $120.77 million. The reported number represents a year-over-year change of -10%.Net Sales- Crop Protection- Herbicides: $1.03 billion versus the two-analyst average estimate of $912.97 million. The reported number represents a year-over-year change of +19.4%.Net Sales- Crop Protection- Insecticides: $377 million versus $360.32 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +12.2% change.Net Sales- Crop Protection- Fungicides: $334 million versus $324.07 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9.9% change.Net Sales- Seed- Soybean: $306 million compared to the $320.25 million average estimate based on two analysts. The reported number represents a change of +0.3% year over year.Net Sales- Seed- Corn: $2.37 billion versus $2.18 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +14.7% change.Net Sales- Seed- Other oilseeds: $245 million versus $251.15 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9.9% change.Operating EBITDA- Seed: $1.03 billion versus $948.01 million estimated by three analysts on average.Operating EBITDA- Corporate: $-30 million versus the three-analyst average estimate of $-43.83 million.View all Key Company Metrics for Corteva, Inc. here>>>
Shares of Corteva, Inc. have returned -3% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
INDIANAPOLIS, May 7, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Chief Executive Officer Chuck Magro and Executive Vice President and Chief Financial Officer David Johnson will speak at the 2026 BMO Global Farm to Market conference at 11:00 a.m. EDT on Thursday, May 14, 2026.
Corteva NYSE: CTVA reported a stronger-than-expected start to 2026, with management pointing to broad demand for seed and crop protection products, favorable timing in North American seed deliveries and continued cost savings as key drivers of first-quarter earnings growth.
Indianapolis, Indiana and Johnston, Iowa Chosen INDIANAPOLIS and JOHNSTON, Iowa, May 12, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today that "New Corteva," its future crop protection company, will be headquartered in Indianapolis, Indiana, and Vylor, its advanced seed and genetics company, will be headquartered in Johnston, Iowa, both following the current company's planned separation in the fourth quarter of 2026. The decision underscores both companies' commitment to their employees, deep community roots and legacy of agricultural innovation in both Iowa and Indiana.
Key Takeaways Mission Produce's Marketing and Distribution segment is the core driver of overall earnings.AVO's segment sales fell 21% in Q1, but adjusted EBITDA rose 33% to $12.9 million.Higher avocado volumes and stronger per-unit margins offset lower industry pricing. Mission Produce, Inc. (AVO - Free Report) derives much of its earnings power from its Marketing and Distribution segment, making this business the core driver of overall performance. The segment benefits from the company’s vertically integrated model, which combines sourcing, ripening, packing and logistics capabilities to deliver avocados efficiently to retail and foodservice customers. As Mission Produce continues to expand customer relationships and increase throughput, the strength of this segment remains central to the company’s long-term investment case.
The latest quarterly results underscore the resilience of this business. In first-quarter fiscal 2026, Marketing and Distribution net sales declined 21% to $234.8 million due to lower avocado prices, but segment-adjusted EBITDA climbed 33% to $12.9 million. The improvement was driven by a 14% increase in avocado volumes and stronger per-unit margins, highlighting management’s ability to focus on profitability rather than simply top-line growth. This performance demonstrates the segment’s capacity to generate earnings even when industry pricing softens.
The outlook for the segment remains favorable, supported by structural growth in avocado consumption and Mission Produce’s expanding global sourcing network. Rising household penetration, strong health and wellness trends and deeper customer partnerships should continue to support volume gains over time. While near-term profitability can fluctuate with pricing and sourcing dynamics, the segment’s scale, operational discipline and proven ability to convert volume growth into EBITDA expansion make it a significant competitive advantage and a key pillar of Mission Produce’s long-term growth strategy.
Operational Strength Powers Growth for Corteva and DoleInnovation, scale and efficient supply chains continue to support margin expansion and long-term earnings growth for Corteva, Inc. (CTVA - Free Report) and Dole plc (DOLE - Free Report) .
Corteva derives much of its earnings strength from its Seed and Crop Protection businesses, which benefit from a broad product portfolio, strong pricing discipline and ongoing innovation. The company continues to invest in premium seed traits, biological products and digital agriculture tools that enhance grower productivity and support higher-margin sales. Its global manufacturing and distribution network enables efficient delivery across key agricultural markets, helping convert rising demand into stronger profitability. With the continued adoption of advanced farming technologies and productivity initiatives, Corteva remains well positioned to drive steady earnings growth..
Dole relies on its integrated sourcing, distribution and marketing platform to drive consistent operating performance across its fresh produce portfolio. The company’s scale and global logistics capabilities allow it to efficiently supply bananas, pineapples and other produce to retail and foodservice customers worldwide. By expanding value-added offerings and improving supply-chain efficiency, Dole is enhancing margins while supporting stable volume growth. As consumer demand for fresh and healthy foods remains strong, the company’s operational discipline and diversified footprint should continue to support long-term earnings and cash flow growth.
AVO’s Price Performance, Valuation & EstimatesShares of Mission Produce have lost 12.1% in the last three months against the industry’s growth of 8%.
Image Source: Zacks Investment Research
From a valuation standpoint, AVO trades at a forward price-to-earnings ratio of 20.33X, significantly above the industry’s average of 15.89X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AVO’s fiscal 2026 earnings suggests a year-over-year decline of 15.2%, while that for fiscal 2027 indicates growth of 5.9%. The company’s EPS estimates for fiscal 2026 and 2027 have remained stable in the past seven days.
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its second quarter 2026 earnings on Thursday, July 30, 2026, after the stock market close via press release and its website. The earnings will be presented in a live webcast on Friday, July 31, 2026, at 9:00 a.m. Eastern Time.
The slide presentation that accompanies the webcast will be posted on the Company's Investor Events and Presentations page. A replay of the webcast will be available on the Investor Events and Presentations page until July 31, 2027.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
Key Takeaways AVO posted Q1 FY26 revenues of $278.6M, down 16.6%, as avocado prices fell about 30%.AVO's adjusted EBITDA rose 5% to $18.5M, with gross margin up 190 bps to 11.3%.AVO plans Calavo Growers deal to diversify offerings and target at least $25M cost synergies in 18 months. Mission Produce, Inc. (AVO - Free Report) is navigating a challenging pricing environment, but its latest results suggest that the company’s business model remains more resilient than headline revenue trends indicate. Although an abundant avocado supply has pressured industry pricing and squeezed margins in certain areas, Mission Produce continues to benefit from strong volume growth, disciplined operational execution and the flexibility of its vertically integrated platform. These strengths are helping the company offset external market volatility and maintain earnings momentum.
The company’s first-quarter fiscal 2026 performance highlighted this resilience. Revenues declined 16.6% year over year to $278.6 million as avocado prices fell roughly 30%, but adjusted EBITDA still increased 5% to $18.5 million. Gross margin expanded 190 basis points to 11.3%, while the Marketing and Distribution segment posted a 33% increase in adjusted EBITDA to $12.9 million, supported by 14% growth in avocado volumes and improved per-unit margins. These results demonstrate the company’s ability to protect profitability even when pricing conditions become less favorable.
Although management expects second-quarter adjusted EBITDA to decline year over year amid continued pricing pressure and delayed California harvest activity, Mission Produce remains optimistic about its long-term outlook. The company continues to benefit from favorable avocado consumption trends, rising household penetration and strategic investments aimed at improving asset utilization.
Additionally, the pending acquisition of Calavo Growers is expected to strengthen Mission Produce’s market position, diversify its product offerings and generate at least $25 million in annualized cost synergies within 18 months of closing. With solid demand tailwinds and an expanding operating platform, Mission Produce appears well-positioned to support long-term EBITDA growth despite near-term pricing and margin pressures.
Steady Demand Helps CTVA and DOLE Weather Cost PressuresCorteva, Inc. (CTVA - Free Report) and Dole plc (DOLE - Free Report) show resilience as disciplined execution and steady demand help offset margin and cost pressures.
Corteva delivered a resilient performance despite ongoing cost and pricing pressures across the agricultural sector. The company continued to benefit from strong seed demand, disciplined cost controls and growth in its crop protection business, which supported profitability even amid softer market conditions. Management highlighted improving operational efficiency and stable farmer demand trends as key drivers of earnings resilience, positioning Corteva well for long-term growth despite near-term headwinds in commodity pricing and global agriculture markets.
Dole demonstrated resilience in a challenging produce environment through steady volume trends and disciplined execution across its diversified fruit portfolio. While pricing pressures and supply-chain costs continued to weigh on margins in certain segments, the company benefited from stable demand, improving operational efficiencies and balanced geographic exposure. Management remains focused on productivity initiatives and strategic investments aimed at strengthening profitability and cash flow generation, reinforcing Dole’s ability to navigate volatile market conditions.
AVO’s Price Performance, Valuation & EstimatesShares of Mission Produce have lost 16% in the last three months against the industry’s growth of 0.2%.
Image Source: Zacks Investment Research
From a valuation standpoint, AVO trades at a forward price-to-earnings ratio of 19.14X, significantly above the industry’s average of 15.29X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AVO’s fiscal 2026 earnings suggests a year-over-year decline of 15.9%, while that for fiscal 2027 indicates growth of 5.9%. The company’s EPS estimates for fiscal 2026 and 2027 have remained stable in the past seven days.
Image Source: Zacks Investment Research
AVO stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
INDIANAPOLIS, June 10, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Chief Financial Officer, David Johnson, and Chief Technology and Digital Officer, Sam Eathington, will speak at Wolfe's third annual Materials of the Future conference at 8:35 a.m. Eastern Time on Wednesday, June 17, 2026.
The Agriculture - Operations industry is riding on long-term tailwinds as value-chain innovation and healthier, sustainable food trends reshape growth. CTVA, ADM, SMG, AGRO and AVO look promising.
